Predicted protein targets (top 4)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.31 |
| ▸ | MEN1 | O00255 | 1/20 | 0.30 |
| ▸ | MAPT | P10636 | 1/20 | 0.30 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL28437243 | 0.73 | ACLY (0.39) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL12170102 | 0.71 | MAPT (0.50) | MEN1MAPTKMT2A | |
| SCHEMBL29011114 | 0.71 | MEN1 (0.34) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL28696640 | 0.67 | RPS6KB2 (0.35) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL20630123 | 0.67 | TXNRD1 (0.33) | SMN1; SMN2MAPT | |
| SCHEMBL28399995 | 0.66 | MAPT (0.32) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL9940784 | 0.64 | MAPT (0.44) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL20630830 | 0.63 | KMT2A (0.36) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL26201427 | 0.63 | KDM4E (0.34) | SMN1; SMN2MEN1MAPTKMT2A | |
| SCHEMBL21637594 | 0.63 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11031557-B2 | Conjugated polymers based on terthiophene and their applications | RAYNERGY TEK INC. (TW) | 2021-06-08 | — | — | US | disclosed |
| US-20200052217-A1 | CONJUGATED POLYMERS BASED ON TERTHIOPHENE AND THEIR APPLICATIONS | RAYNERGY TEK INC. (TW) | 2020-02-13 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200052217-A1 | CONJUGATED POLYMERS BASED ON TERTHIOPHENE AND THEIR APPLICATIONS | TERT, TTI2, TTI1 | SMN1; SMN2 1149/4885MEN1 4399/4885MAPT 31/4885 |
| US-11031557-B2 | Conjugated polymers based on terthiophene and their applications | TERT, TTI2, TTI1 | SMN1; SMN2 1149/4885MEN1 4399/4885MAPT 31/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.